(C15H14O3) (Valgera et al. CCDC 710835, 2016) [2] (5) are discussed with the role of the substituent in crystal packing. In vivo, anti-inflammatory activities of all compounds were studied on Wistar strain albino rats. All the compounds exhibited anti-inflammatory activity except 5. Compounds 1, 2, 4 have shown moderate-to-intermediate effects on inhibitory properties. Compound (3) with restricted rotation
三种苯基二聚体化合物,即3,3'-二甲酰基二苯氧基
乙烷(C 16 H 14 O 4)(1),1-(4- [2-(4-乙酰基-苯氧基)-乙氧基]-苯基)-乙酮(C 17 H 16 N 2 O 3)(2),1- 4- [2-(4-乙酰基-苯氧基甲基)-苄氧基]-苯基}-乙酮(C 24 H 22 O 4)(3)表征,包括其晶体结构的确定。两种化合物4、4 ' -(亚乙基二氧基)二
苯甲醛)(C 16 H 14 O 4)的结构性质)(Tewari等,Acta Cryst。E63:o1930,2007)[1](4)和4-(2-Phenoxy-ethoxy)-benzaldehyde(C 15 H 14 O 3)(Valgera等,CCDC 710835,2016 )[2](5)讨论了取代基在晶体堆积中的作用。在体内,在Wistar白化病大鼠身上研究了所有化合物的抗炎活性。除5外,所有化合物均表现出抗